CHCHematologyNews CHC 2016 News in Hematology: Non-Hodgkin’s Lymphoma Management in Relapsed/Refractory Follicular Lymphoma – Dr. Stefano Luminari Unmet needs exist in the R/R…jwood@krftwrk.caOctober 3, 2016
CHCHematologyNews CHC 2016 News in Hematology: Hodgkin’s Lymphoma Staging and Response Assessment in Lymphoma: Dr. Richard Tsang FDG-PET is widely available and funded…jwood@krftwrk.caSeptember 30, 2016
CHCHematologyNews CHC 2016 News in Hematology: Plasma Cell Dyscrasias Plasmacytoma – Dr. Darrel White Solitary plasmacytoma is relatively uncommon, occurring in approximately 5% of…jwood@krftwrk.caSeptember 30, 2016
CHCHematologyNews CHC 2016 News in Hematology: Myeloproliferative Neoplasms A Clinician’s Guide to MPN Diagnosis in 2016 - Dr. Hubert Tsui Revisions to the…jwood@krftwrk.caSeptember 30, 2016
CHCHematologyNews CHC 2016 News in Hematology: Myeloproliferative Neoplasms The MPN World in the JAK2 Inhibitor Era - Dr. Richard Silver Despite the recent advances…jwood@krftwrk.caSeptember 30, 2016
CHCHematologyNews CHC 2016 News in Hematology: Chronic Lymphocytic Leukemia Management of Ibrutinib Failure – Dr. Matthew Davids The oral BTK inhibitor ibrutinib has revolutionized…jwood@krftwrk.caSeptember 30, 2016